Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × tucatinib × Breast × Clear all

Status

Recruiting 13 Completed 8 Active not recruiting 7 Withdrawn 4 Terminated 3 Not yet recruiting 1 No longer available 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neoplasms by Site 1 Neoplasms 1 Breast Neoplasms 1 Breast Diseases 1 Brain Neoplasms 1

Interventions

veliparib 2 tucatinib 1 pegilodecakin 1 palbociclib 1 leronlimab 1 iniparib 1 glembatumumab vedotin 1 Vinorelbine 1 Letrozole 1 Everolimus 1 Cisplatin 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03424473 2020-02-25

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.

No longer available

Brain Neoplasms, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon ⚡